Buffalo General joins New York City-based Mount Sinai Health System and Pittsburgh-based UPMC as health systems participating in the trial, according to a March 20 Synchron news release.
The Command Trial will primarily focus on safety while also beginning to assess the efficacy of the Synchron Switch, a brain-computer interface device designed to allow people with limited or no mobility to control technology using their thoughts.
The FDA granted breakthrough device designation to Synchron in August 2020.
